AJP - Heart Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 279: H422-H428, 2000;
0363-6135/00 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (88)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sam, F.
Right arrow Articles by Colucci, W. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sam, F.
Right arrow Articles by Colucci, W. S.
Vol. 279, Issue 1, H422-H428, July 2000

Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart

Flora Sam, Douglas B. Sawyer, Donny L.-F. Chang, Franz R. Eberli, Soeun Ngoy, Mohit Jain, Jay Amin, Carl S. Apstein, and Wilson S. Colucci

Cardiovascular Section, Boston University Medical Center, Myocardial Biology Unit and Cardiac Muscle Research Laboratory, Boston University School of Medicine, Boston, Massachusetts 02118


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

We tested the hypothesis that left ventricular (LV) remodeling late after myocardial infarction (MI) is associated with myocyte apoptosis in myocardium remote from the infarcted area and is related temporally to LV dilation and contractile dysfunction. One, four, and six months after MI caused by coronary artery ligation, LV volume and contractile function were determined using an isovolumic balloon-in-LV Langendorff technique. Apoptosis and nuclear morphology were determined by terminal deoxynucleotidyl transferase-mediated nick end-labeling (TUNEL) and Hoechst 33258 staining. Progressive LV dilation 1-6 mo post-MI was associated with reduced peak LV developed pressure (LVDP). In myocardium remote from the infarct, there was increased wall thickness and expression of atrial natriuretic peptide mRNA consistent with reactive hypertrophy. There was a progressive increase in the number of TUNEL-positive myocytes from 1 to 6 mo post-MI (2.9-fold increase at 6 mo; P < 0.001 vs. sham). Thus LV remodeling late post-MI is associated with increased apoptosis in myocardium remote from the area of ischemic injury. The frequency of apoptosis is related to the severity of LV dysfunction.

heart failure; myocardium; left ventricle; remodeling


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

AFTER MYOCARDIAL INFARCTION (MI) there is progressive myocardial remodeling characterized by left ventricular (LV) dilation, contractile dysfunction (30, 33), myocyte hypertrophy (19), and altered expression of contractile (39), calcium-handling (37), and extracellular matrix proteins (38). In mice (4, 25), there is evidence that apoptosis of cardiac myocytes occurs transiently during the first several days after MI in the ischemic area but not in myocardium remote from the area of ischemic injury. However, apoptosis of cardiac myocytes has been observed in LV myocardium from patients with chronic cardiomyopathy late after MI (28), leading to the thesis that myocyte apoptosis contributes to the chronic progression of myocardial failure (2).

Therefore, an important unresolved question is whether myocyte apoptosis occurs late (i.e., months) after MI in tissue remote from the ischemic injury. Several factors that may be present in remodeling myocardium (6, 12, 17, 23, 40) have been shown to stimulate myocyte apoptosis in vitro, including increased mechanical strain (11), neurohormones (13), reactive oxygen species (1, 35), and inflammatory cytokines (21). Because these potential stimuli for apoptosis are not restricted to the infarct, per se, it is possible that late remodeling is associated with apoptosis in myocardium remote from the area of ischemic damage.

The goal of this study was to test the hypothesis that LV remodeling late after MI is associated with apoptosis in myocardium remote from the infarct and, if so, to determine the temporal course of apoptosis and its relationship to the progression of structural and functional remodeling. Accordingly, we determined LV dilation and maximal LV contractile function using an isovolumic balloon-in-LV Langendorff technique and measured myocyte apoptosis by terminal deoxynucleotidyl transferase-mediated nick end-labeling (TUNEL) in hearts from mice 1, 4, and 6 mo after coronary artery ligation.


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Myocardial infarction. MI was induced in male CD-1 mice (Charles River) by ligation of the left coronary artery as previously described (15, 26). The mice were 8-10 wk old and weighed 30-32 g. The animals were killed and studied at 1, 4, and 6 mo after MI. The protocol was approved by the Institutional Animal Care and Use committee at Boston University School of Medicine.

Langendorff preparation. LV volume and function were determined using an isolated, isovolumic red cell-perfused Langendorff heart preparation as previously described (15). After 20 min of baseline perfusion at a systolic pressure of 80-100 mmHg and a pacing rate of 7 Hz (420 beats/min), the intracardiac balloon volume was set to the lowest volume at which minimal LV pressure tracings could be recorded. This volume (V0) was defined as the "zero" volume. Systolic and diastolic pressure-volume relationships were established by increasing the LV balloon volume in 5-µl increments using an air-tight Hamilton syringe. LV functional measurements were obtained 1-2 min after each increment in volume when a new steady state was reached. The LV volume was increased up to a value (Vmax) at which peak LV developed pressure (LVDP) was reached and a further increase in balloon volume led to a decrease in peak LVDP.

After pressure-volume curves were obtained, the heart was perfused with saline for a few minutes to clear red cells from the LV drain. With the LV balloon volume set to an end-diastolic pressure of 5 mmHg, the heart was arrested in diastole with KCl and perfusion-fixed with 10% buffered Formalin at a coronary perfusion pressure of 80 mmHg. After 3 days of fixation, the balloon was removed, excess Formalin was blotted, and the heart was weighed.

Infarct size. After fixation, the LV was embedded in paraffin, and sections were taken at the apex, midcavity, and base and stained with trichrome Masson. Infarct size was determined as the mean percentage of epicardial and endocardial circumference occupied by scar tissue for the three sections as previously described by Pfeffer et al. (32).

Northern hybridization. Mice were killed at 1, 4, and 6 mo after MI, the atria and right ventricle were removed, and the LV was weighed. The infarct was carefully dissected along with a 0.5- to 1-mm rim of normal-appearing tissue (peri-infarct region) to yield samples referred to as "infarct/peri-infarct" and "remote," which were weighed and rapidly frozen in liquid nitrogen. Infarct size for these hearts was expressed as the weight ratio of the infarct/peri-infarct sample to the whole LV (i.e., before removal of the infarct). Only samples from hearts with infarcts >= 30% were used. mRNA was extracted and subjected to Northern hybridization as previously described (8) using a full-length cDNA for rat prepro-atrial natriuretic peptide (ANP). Blots were exposed to X-ray film and quantified by laser densitometry using Molecular Analyst software (Bio-Rad, Hercules, CA). mRNA levels were normalized by reprobing with an oligonucleotide complimentary to 18S rRNA (8).

TUNEL and Hoechst 33258 staining. Sections 5 µm thick from the LV apex, midcavity, and base were stained with TUNEL using a cell death detection assay (Boehringer Mannheim, Indianapolis, IN) according to the manufacturer's instructions. Sections were incubated with the TUNEL reaction mixture containing terminal deoxynucleotidyl transferase and fluorescein-dUTP for 1 h at 37°C. Staining with Hoechst 33258 (10 µM for 30 min) was performed on the same sections after TUNEL staining for visualization of nuclei. Sections were visualized by fluorescence microscopy using a Nikon Diaphot 300 microscope, and images were acquired with a Bioquant (Memphis, TN) image acquisition and analysis system using an Optronics camera.

For each heart, the number of TUNEL-positive myocyte nuclei was scored per unit area and per 105 myocyte nuclei. The number of TUNEL-positive myocyte nuclei in the myocardium remote from the infarct was counted manually in the three sections (apex, midcavity, base). Only TUNEL-positive nuclei that appeared to be located in cardiac myocytes were counted. The total area of myocardium remote from the infarct was measured in these sections by planimetry from digital images taken at low magnification using SigmaScan Pro image analysis software (version 4.0; Jandel Scientific, San Rafael, CA). The number of nuclei per unit area for each heart was estimated by counting the number of Hoechst-positive nuclei under ultraviolet illumination in five fields (totaling >1 mm2) from digital images using manual thresholding and automated counting routines (Bioquant software). There were scattered surviving myocytes within the infarcts, particularly along the endocardial surface, and occasional TUNEL-positive nuclei were seen within these myocytes.

Caspase activity. Total myocardial caspase activity was measured using the ApoAlert CPP32/Caspase-3 assay kit from Clontech (Palo Alto, CA). Samples of ventricular myocardium remote from the infarct and sham-operated animals were removed and rapidly frozen as described for isolation of mRNA (see Northern hybridization). Samples were finely ground under liquid nitrogen using a mortar and pestle. Samples of 20-40 mg of tissue were lysed using the cell lysis buffer from the kit using 100 µl of buffer per 10 mg of tissue and were left on ice for 20 min. Samples were centrifuged at 10,000 g for 3 min, and CPP32 (cysteine protease protein-32) activity was measured in 50-µl volumes of supernatant per the manufacturer's instructions. Protein concentration in the same samples was measured using the Bradford assay, and units of caspase activity were calculated per microgram of protein.

Statistical analysis. Differences in pressure-volume relationships were tested by two-way analysis of variance (ANOVA) for repeated measures. When two-way ANOVA indicated a significant (P < 0.05) difference, data were further examined by the method of least significant differences. Group differences for a single variable were tested by Student's unpaired t-test (two-tailed). A P value of <0.05 was considered significant. All data are presented as means ± SE.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Myocardial infarction. A total of 140 mice were studied. Of the 122 mice that underwent coronary artery ligation, ~50% died in the first 24 h after surgery. In the surviving mice, the 6-mo survival rate as assessed by Kaplan-Meier analysis was 72 ± 7% (vs. 100% in sham-operated mice).

Coronary artery ligation in the mouse results in transmural infarction and subsequent scar formation. Infarct size ranged from <10% to >50%. The extent of LV remodeling is related to MI size (29, 31, 32), and therefore infarcts involving <30% of the LV were excluded from further analysis. Of the 33 hearts with infarcts >= 30%, infarct size averaged 40 ± 2% (range: 30-55%). Infarct size was similar in the groups studied at 1, 4, and 6 mo, averaging 44 ± 3, 35 ± 2, and 40 ± 3% (P = not significant), respectively.

Heart weight. Body weight increased between 1 and 4 mo in both the MI and sham groups, reflecting normal age-related growth (Table 1). There was no difference in body weight between MI and sham groups at 1, 4, or 6 mo. Heart weight likewise increased between 1 and 4 mo but was greater in the MI group at each time point, with or without normalization to body weight. Neither ascites nor pleural effusion was found at death in any animal, and ratios of wet to dry lung and liver weights were similar in the MI and sham groups (data not shown).

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Heart and body weights

LV volume and function. LV size and function were measured using the isovolumic, blood-perfused (balloon-in-LV) Langendorff preparation paced at 7 Hz (15). The LV end-diastolic pressure-volume relationship was shifted rightward (vs. sham) at 1, 4, and 6 mo after MI, and the degree of rightward shift increased progressively from 1 to 6 mo (Fig. 1).


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 1.   Mean left ventricular (LV) end-diastolic pressure-volume relationships in hearts from mice 1 (A), 4 (B), or 6 mo (C) after myocardial infarction (MI) and their sham-operated controls. At 1, 4, and 6 mo the volumes of the infarcted LVs are greater than those from age-matched sham-operated controls (*P < 0.05 for all time points). Among the infarcted hearts (MI), LV volume at 6 mo was greater than that at 1 or 4 mo (P < 0.05). Values are the mean data for 8 MI and 6 sham hearts at 1 mo, 7 MI and 6 sham hearts at 4 mo, and 13 MI and 6 sham hearts at 6 mo. LVEDP, LV end-diastolic pressure.

LV systolic pressure at a LV end-diastolic pressure (LVEDP) of 5 mmHg was lower in MI (vs. sham) hearts at 1, 4, and 6 mo, whereas LV peak systolic pressure in MI hearts was decreased only at 6 mo (Table 2). In MI (vs. sham) hearts at 1, 4, and 6 mo, the LVDP was decreased and shifted rightward over the entire LV volume range tested (Fig. 2A). Because LV volumes varied in the MI groups, the LVDP for each heart was normalized to the volume at the maximal developed pressure (Vmax) as described by Stromer et al. (36) (Fig. 2B). With this normalization for volume, peak LVDP in MI hearts decreased progressively between 1 and 6 mo. In sham-operated mice, the peak LVDP was similar at 1, 4, and 6 mo (109 ± 5, 120 ± 5, and 119 ± 1 mmHg, respectively). Peak LVDP decreased progressively from 1 to 6 mo in the infarcted hearts (P < 0.0001 by log rank test). At 6 mo, peak LVDP was decreased compared with shams (P = 0.004). The relationship between peak LVDP and LVEDP was likewise preserved at 1 mo and decreased progressively at 4 and 6 mo (data not shown).

                              
View this table:
[in this window]
[in a new window]
 
Table 2.   Left ventricular systolic pressure at an end-diastolic pressure of 5 mmHg or at peak systolic pressure



View larger version (31K):
[in this window]
[in a new window]
 
Fig. 2.   A: mean curves describing LV developed pressure vs. volume in mice 1, 4, and 6 mo post-MI and their sham-operated controls. The curves are shifted progressively rightward and downward, and the peak developed pressure declines progressively at 4 and 6 mo (*P < 0.05 vs. sham; **P < 0.01 vs. sham). The numbers of hearts in each group are as reported in Fig. 1. B: peak LV developed pressure at 1, 4, and 6 mo post-MI normalized to the LV volume that yielded the maximum developed pressure (referred to as Vmax). The curves were shifted rightward in infarcted hearts at 4 and 6 mo (**P = 0.003 vs. shams; ***P = 0.001 vs. shams). The numbers of hearts in each group are as reported in Fig. 1.

ANP mRNA expression. Prepro-ANP mRNA was measured by Northern hybridization as a marker of fetal gene expression (Fig. 3A). Infarcted hearts were dissected into two parts, one consisting of the infarct with the peri-infarct rim and the other consisting of the remaining noninfarcted (i.e., remote) LV. In noninfarcted LV, ANP mRNA was not increased (vs. shams) at 1 mo but was increased 7- and 4-fold at 4 and 6 mo, respectively (Fig. 3B). In the infarct/peri-infarct sample, ANP mRNA was increased 10-, 10-, and 9-fold at 1, 4, and 6 mo, respectively.


View larger version (42K):
[in this window]
[in a new window]
 
Fig. 3.   Expression of prepro-atrial natriuretic peptide (ANP) mRNA in LV myocardium after MI. A: representative Northern hybridizations for ANP and 18S in LV from sham-operated mice and from the remote or infarcted (including peri-infarct rim) regions of infarcted hearts. B: mean levels of ANP mRNA (normalized to 18S RNA) in the infarct/peri-infarct and remote regions compared with age-matched sham-operated hearts (*P < 0.05 vs. shams; ***P < 0.001 vs. shams; n = 4 hearts for each group).

TUNEL staining, nuclear morphology, and caspase activity. Cross sections from the LV apex, midcavity, and base of each heart were stained by the in situ TUNEL technique (Fig. 4A). There were rare TUNEL-positive nuclei in sham-operated animals. In myocardium remote from the infarct, the number of TUNEL-positive cells appeared to be increased at all time points. High-power microscopy demonstrated that TUNEL-positive staining was localized primarily to nuclei of myocytes, which had evidence of chromatin condensation by Hoechst staining (Fig. 4A). This impression was confirmed by confocal microscopy in selected sections. TUNEL-positive cells appeared to be randomly distributed throughout the remote myocardium.


View larger version (91K):
[in this window]
[in a new window]
 
Fig. 4.   Apoptosis in remote myocardium late post-MI. A: representative terminal deoxynucleotidyl transferase-mediated nick end-labeling (TUNEL)- (left) and Hoechst 33258-stained sections (right) from the remote (i.e., noninfarcted) region of a mouse heart 6 mo post-MI. The arrows indicate TUNEL-positive cells and the corresponding Hoechst 33258-stained nuclei (calibration bar = 50 µm). B: mean number of TUNEL-positive nuclei per 105 myocytes in the remote myocardium at 1, 4, and 6 mo post-MI. The number of TUNEL-positive myocytes (27 ± 8/105 nuclei) in sham-operated mice was similar for all time points. The number of TUNEL-positive cells increased progressively from 1 to 6 mo (P = 0.005 by log rank test), reaching significance at 6 mo (**P = 0.002 vs. sham; n = 4-6 hearts for each group).

The TUNEL-positive myocytes in myocardium remote from the infarct were counted and normalized per area of myocardium and per 105 total nuclei (identified by Hoechst 33258 staining in the same sections). The number of TUNEL-positive myocytes in sham-operated animals was similar at all time points studied, and so data from these animals were pooled. The number of TUNEL-positive myocytes was increased in infarcted hearts (vs. shams) by 1.4-, 1.9-, and 2.9-fold at 1, 4, and 6 mo, respectively, reaching statistical significance at 6 mo (Fig. 4B). Similar results were obtained when TUNEL-positive myocytes were normalized to the area of myocardium (data not shown).

Caspase-3 activity in myocardium was 0.22 ± 0.01 U/mg protein in sham-operated mice and increased by 43 ± 12% to 0.31 ± 0.03 U/mg protein (P < 0.04; n = 3-5) in remote myocardium from mice 6 mo post-MI.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

In the mouse heart, myocyte apoptosis occurs transiently in the immediate area of ischemic damage for up to several days after MI but not in myocardium remote from the area of ischemia (4, 25). The major new finding of our study is that late (i.e., 1-6 mo) after MI, chronic LV remodeling with chamber dilation and impaired systolic pump function is temporally associated with increased myocyte apoptosis in myocardium remote from the area of initial ischemic damage.

Structural and functional remodeling. Post-MI LV remodeling consists of at least two temporal phases (32). During the early phase (first few days), there is expansion of the infarcted tissue, leading to early LV chamber dilation and increased mechanical stress on the remaining viable myocardium. During the late phase (subsequent weeks to months), there is progressive remodeling of the remote areas of the LV characterized by further chamber dilation, myocardial hypertrophy, reexpression of a fetal phenotype, and progressive deterioration in systolic pump function.

We found that in the mouse between 1 and 6 mo after a moderate to large MI, there is progressive remodeling with LV dilation and reduced systolic pump function. This finding is consistent with observations in the rat (31). Remodeling was associated with hypertrophy of myocardium remote from the MI as evidenced by increases in LV weight and wall thickness. Likewise, there was increased expression of mRNA for ANP, a fetal gene that is reexpressed in hypertrophied myocardium (14, 22). ANP mRNA was increased in both the infarct/peri-infarct and remote LV samples. The increase was greater in the sample consisting of the infarct/peri-infarct margin, in agreement with studies (22) in rats that have shown the highest levels of ANP expression to be in the peri-infarct border zone (22), where wall stress is highest (3).

The isovolumic blood-perfused Langendorff preparation with a balloon in the LV was used to assess LV size and contractile function (15, 20). An advantage of this method is that it allows LV size and function to be measured over a range of LV filling pressures and, thus, provides a full reflection of both chamber dilation and maximal systolic pump capacity (18).

Compared with age-matched sham-operated mice, LV chamber volume in infarcted mice increased progressively from 1 to 6 mo, suggesting that LV dilation is time dependent. LV dilation was associated with a parallel progressive rightward shift in the relationship between LV volume and developed pressure and with a decrease in maximum LVDP at any given volume. The latter is particularly important because LV size in the infarcted mice was larger than in sham-operated mice and varied considerably because of the range of infarct sizes that is inherent in this model.

Late myocyte apoptosis. The mouse MI model has been used to characterize the mode of cell death during the first 7 days after MI (4, 24). In mice 7 days after MI, Li et al. (25) found that LV chamber dilation was associated with evidence of both necrosis and apoptosis of cardiac myocytes in the infarct/peri-infarct region, but not in the septum, which is remote from the area of ischemic damage. Furthermore, they found that, in mice that overexpress insulin-like growth factor-1, there was less apoptosis, less extensive remodeling, and better LV function. During the first 72 h after MI, Bialik et al. (4) also found evidence of myocyte apoptosis that was restricted to the area of hypoxic myocardium. Likewise, in rats apoptosis is localized to the infarct and peri-infarct regions early after MI, with little to none in areas remote from the infarct (10).

We found that late after MI, there was a progressive increase in the number of apoptotic myocytes in myocardium remote from the area of ischemic damage. The assessment of apoptotic myocytes was based primarily on TUNEL staining, which detects double-stranded DNA breakage. TUNEL staining may also identify necrotic cells (7, 16). We observed that TUNEL-positive cells had condensation of nuclear chromatin, which is typical of apoptosis rather than oncocytic necrosis. Although we cannot exclude a contribution from necrotic cells, myocyte necrosis has not been associated with remodeling of remote myocardium. The observed increase in the frequency of apoptotic cells suggests an increased rate of apoptosis. This conclusion depends on the untested, but reasonable, assumption that the duration of time that TUNEL-positive cells are visible remains constant. The observed increase in caspase-3 activity at 6 mo after MI, a key intermediate in the activation of the apoptosis in many cell types (9) including myocytes (5), is consistent with the conclusion that apoptosis is increased in the remote myocardium late after MI.

Survival. The infarcted mice had a reduced survival over 6 mo of this study. Overt heart failure and organ congestion were not found in mice that survived to 6 mo, suggesting that the more severely affected animals had died before that time. We have observed that some mice carried beyond 6 mo experience rapid deterioration and death associated with respiratory distress and increased lung water, suggesting that animals that are compensated at 6 mo may subsequently progress to overt heart failure. Thus the animals included in our analysis may have less LV dysfunction and apoptosis than those that died before euthanization.

Implications. These observations raise several important questions. First, what is the cause of increased apoptosis in remote myocardium? In vitro, several factors that may be relevant to chronic remodeling can stimulate myocyte death by apoptosis, including mechanical stress (11), angiotensin (23), inflammatory cytokines (34), norepinephrine (13), and oxidative stress (1). The progressive increase in the number of apoptotic myocytes suggests that the stimulus for apoptosis (e.g., mechanical stress) increases with time after MI. We did not determine which factor(s) might be stimulating apoptosis late post-MI. However, the estimated LV diastolic wall stress (27) was ~2-4 kdyn/cm2 in shams (assuming an LVEDP of 2-5 mmHg) and increased by ~5-10-fold at 6 mo post-MI (assuming an LVEDP of 15 mmHg) (data not shown). These values are similar in magnitude to the mechanical stress that has been shown to cause apoptosis of cardiac myocytes in vitro (11). Thus increased mechanical strain may have been a stimulus for apoptosis late post-MI.

Second, does late myocyte apoptosis contribute to LV remodeling and dysfunction? The strong correlation between the frequency of apoptotic myocytes and the decrement in maximal developed pressure is consistent with this possibility. However, it is also possible that apoptosis is a marker for, rather than the cause of, worse LV function. This model should allow the use of genetically altered mice to address these and other important questions about the role of apoptosis in post-MI remodeling.


    ACKNOWLEDGEMENTS

We gratefully acknowledge the help of Nirva D. Kapasi and Michael R. Winter with data analysis.


    FOOTNOTES

This work was supported in part by National Heart, Lung, and Blood Institute Grants HL-52320, HL-42539, and HL-61639 (to W. S. Colucci) and HL-03878 (to D. B. Sawyer); a Postdoctoral Fellowship from the American Heart Association (AHA), Massachusetts Affiliate (to F. Sam); and a Beginning Grant-in-Aid from the AHA, Massachusetts Affiliate (to D. B. Sawyer).

Address for reprint requests and other correspondence: W. S. Colucci, Cardiovascular Section, Boston Univ. Medical Center, 88 E. Newton St., Boston, MA 02118 (E-mail: wilson.colucci{at}bmc.org).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.

Received 12 August 1999; accepted in final form 11 January 2000.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Aikawa, R, Komuro I, Yamazaki T, Zou Y, Kudoh S, Tanaka M, Shiojima I, Hiroi Y, and Yazaki Y. Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. J Clin Invest 100: 1813-1821, 1997[Web of Science][Medline].

2.   Anversa, P, Kajstura J, and Olivetti G. Myocyte death in heart failure. Curr Opin Cardiol 11: 245-251, 1996[Web of Science][Medline].

3.   Anversa, P, Li P, Zhang X, Olivetti G, and Capasso JM. Ischaemic myocardial injury and ventricular remodelling. Cardiovasc Res 27: 145-157, 1993[Free Full Text].

4.   Bialik, S, Geenen DL, Sasson IE, Cheng R, Horner JW, Evans SM, Lord EM, Koch CJ, and Kitsis RN. Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. J Clin Invest 100: 1363-1372, 1997[Web of Science][Medline].

5.   Black, SC, Huang JQ, Rezaiefar P, Radinovic S, Eberhart A, Nicholson DW, and Rodger IW. Co-localization of the cysteine protease caspase-3 with apoptotic myocytes after in vivo myocardial ischemia and reperfusion in the rat. J Mol Cell Cardiol 30: 733-742, 1998[Web of Science][Medline].

6.   Bristow, MR. Why does the myocardium fail? Insights from basic science. Lancet 352, Suppl 1: SI8-SI14, 1998.

7.   Buja, LM, and Entman ML. Modes of myocardial cell injury and cell death in ischemic heart disease. Circulation 98: 1355-1357, 1998[Free Full Text].

8.   Calderone, A, Takahashi N, Izzo NJ, Jr, Thaik CM, and Colucci WS. Pressure- and volume-induced left ventricular hypertrophies are associated with distinct myocyte phenotypes and differential induction of peptide growth factor mRNAs. Circulation 92: 2385-2390, 1995[Abstract/Free Full Text].

9.   Casciola-Rosen, L, Nicholson DW, Chong T, Rowan KR, Thornberry NA, Miller DK, and Rosen A. Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J Exp Med 183: 1957-1964, 1996[Abstract/Free Full Text].

10.   Cheng, W, Kajstura J, Nitahara JA, Li B, Reiss K, Liu Y, Clark WA, Krajewski S, Reed JC, Olivetti G, and Anversa P. Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp Cell Res 226: 316-327, 1996[Web of Science][Medline].

11.   Cheng, W, Li B, Kajstura J, Li P, Wolin MS, Sonnenblick EH, Hintze TH, Olivetti G, and Anversa P. Stretch-induced programmed myocyte cell death. J Clin Invest 96: 2247-2259, 1995.

12.   Colucci, WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol 80: 15L-25L, 1997[Medline].

13.   Communal, C, Singh K, Pimentel DR, and Colucci WS. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta -adrenergic pathway. Circulation 98: 1329-1334, 1998[Abstract/Free Full Text].

14.   Drexler, H, Hanze J, Finckh M, Lu W, Just H, and Lang RE. Atrial natriuretic peptide in a rat model of cardiac failure. Atrial and ventricular mRNA, atrial content, plasma levels, and effect of volume loading. Circulation 79: 620-633, 1989[Abstract/Free Full Text].

15.   Eberli, FR, Sam F, Ngoy S, Apstein CS, and Colucci WS. Left-ventricular structural and functional remodeling in the mouse after myocardial infarction: assessment with the isovolumetrically-contracting Langendorff heart. J Mol Cell Cardiol 30: 1443-1447, 1998[Web of Science][Medline].

16.   Gold, R, Schmied M, Giegerich G, Breitschopf H, Hartung HP, Toyka KV, and Lassmann H. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest 71: 219-225, 1994[Web of Science][Medline].

17.   Hill, MF, and Singal PK. Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. Circulation 96: 2414-2420, 1997[Abstract/Free Full Text].

18.   James, JF, Hewett TE, and Robbins J. Cardiac physiology in transgenic mice. Circ Res 82: 407-415, 1998[Abstract/Free Full Text].

19.   Kajstura, J, Zhang X, Reiss K, Szoke E, Li P, Lagrasta C, Cheng W, Darzynkiewicz Z, Olivetti G, and Anversa P. Myocyte cellular hyperplasia and myocyte cellular hypertrophy contribute to chronic ventricular remodeling in coronary artery narrowing-induced cardiomyopathy in rats. Circ Res 74: 383-400, 1994[Abstract/Free Full Text].

20.   Kameyama, T, Chen Z, Bell SP, Fabian J, and LeWinter MM. Mechanoenergetic studies in isolated mouse hearts. Am J Physiol Heart Circ Physiol 274: H366-H374, 1998[Abstract/Free Full Text].

21.   Krown, KA, Page MT, Nguyen C, Zechner D, Gutierrez V, Comstock KL, Glembotski CC, Quintana PJ, and Sabbadini RA. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest 98: 2854-2865, 1996[Web of Science][Medline].

22.   Larsen, TH, and Saetersdal T. Regional appearance of atrial natriuretic peptide in the ventricles of infarcted rat hearts. Virchows Arch B Cell Pathol Incl Mol Pathol 64: 309-314, 1993[Web of Science][Medline].

23.   Leri, A, Claudio PP, Li Q, Wang X, Reiss K, Wang S, Malhotra A, Kajstura J, and Anversa P. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J Clin Invest 101: 1326-1342, 1998[Web of Science][Medline].

24.   Li, B, Li Q, Wang X, Jana KP, Redaelli G, Kajstura J, and Anversa P. Coronary constriction impairs cardiac function and induces myocardial damage and ventricular remodeling in mice. Am J Physiol Heart Circ Physiol 273: H2508-H2519, 1997[Abstract/Free Full Text].

25.   Li, Q, Li B, Wang X, Leri A, Jana KP, Liu Y, Kajstura J, Baserga R, and Anversa P. Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Invest 100: 1991-1999, 1997[Web of Science][Medline].

26.   Michael, LH, Entman ML, Hartley CJ, Youker KA, Zhu J, Hall SR, Hawkins HK, Berens K, and Ballantyne CM. Myocardial ischemia and reperfusion: a murine model. Am J Physiol Heart Circ Physiol 269: H2147-H2154, 1995[Abstract/Free Full Text].

27.   Mirsky, I. Elastic properties of the myocardium: a quantitative approach with physiological and clinical applications. In: Handbook of Physiology. The Cardiovascular System. The Heart. Bethesda, MD: Am. Physiol. Soc, 1979, sect. 2, vol. I, chapt. 14, p. 497-531.

28.   Olivetti, G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Di Loreto C, Beltrami CA, Krajewski S, Reed JC, and Anversa P. Apoptosis in the failing human heart. N Engl J Med 336: 1131-1141, 1997[Abstract/Free Full Text].

29.   Patten, RD, Aronovitz MJ, Deras-Mejia L, Pandian NG, Hanak GG, Smith JJ, Mendelsohn ME, and Konstam MA. Ventricular remodeling in a mouse model of myocardial infarction. Am J Physiol Heart Circ Physiol 274: H1812-H1820, 1998[Abstract/Free Full Text].

30.   Pfeffer, JM, Pfeffer MA, Fletcher PJ, and Braunwald E. Ventricular performance in rats with myocardial infarction and failure. Am J Med 76: 99-103, 1984[Web of Science][Medline].

31.   Pfeffer, JM, Pfeffer MA, Fletcher PJ, and Braunwald E. Progressive ventricular remodeling in rat with myocardial infarction. Am J Physiol Heart Circ Physiol 260: H1406-H1414, 1991[Abstract/Free Full Text].

32.   Pfeffer, MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, and Braunwald E. Myocardial infarct size and ventricular function in rats. Circ Res 44: 503-512, 1979[Abstract/Free Full Text].

33.   Pfeffer, MA, Pfeffer JM, and Lamas GA. Development and prevention of congestive heart failure following myocardial infarction. Circulation 87: IV120-5, 1993.

34.   Pinsky, DJ, Cai B, Yang X, Rodriguez C, Sciacca RR, and Cannon PJ. The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta . J Clin Invest 95: 677-685, 1995.

35.   Siwik, DA, Tzortzis JD, Pimental DR, Chang DL, Pagano PJ, Singh K, Sawyer DB, and Colucci WS. Inhibition of copper-zinc superoxide dismutase induces cell growth, hypertrophic phenotype, and apoptosis in neonatal rat cardiac myocytes in vitro. Circ Res 85: 147-153, 1999[Abstract/Free Full Text].

36.   Stromer, H, Cittadini A, Szymanska G, Apstein CS, and Morgan JP. Validation of different methods to compare isovolumic cardiac function in isolated hearts of varying sizes. Am J Physiol Heart Circ Physiol 272: H501-H510, 1997[Abstract/Free Full Text].

37.   Swynghedauw, B. Remodeling of the heart in chronic pressure overload. Basic Res Cardiol 86, Suppl 1: 99-105, 1991.

38.   Weber, KT. Extracellular matrix remodeling in heart failure. A role for de novo angiotensin II generation. Circulation 96: 4065-4082, 1997[Free Full Text].

39.   Yue, P, Long CS, Austin R, Chang KC, Simpson PC, and Massie BM. Post-infarction heart failure in the rat is associated with distinct alterations in cardiac myocyte molecular phenotype. J Mol Cell Cardiol 30: 1615-1630, 1998[Web of Science][Medline].

40.   Yue, P, Massie BM, Simpson PC, and Long CS. Cytokine expression increases in nonmyocytes from rats with postinfarction heart failure. Am J Physiol Heart Circ Physiol 275: H250-H258, 1998[Abstract/Free Full Text].


Am J Physiol Heart Circ Physiol 279(1):H422-H428
0363-6135/00 $5.00 Copyright © 2000 the American Physiological Society



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. Yoo, A. Lemaire, S. Mangmool, M. J. Wolf, A. Curcio, L. Mao, and H. A. Rockman
{beta}1-Adrenergic receptors stimulate cardiac contractility and CaMKII activation in vivo and enhance cardiac dysfunction following myocardial infarction
Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1377 - H1386.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Park, Y.-T. Shen, V. Gaussin, G. R. Heyndrickx, J. Bartunek, R. R. G. Resuello, F. F. Natividad, R. N. Kitsis, D. E. Vatner, and S. F. Vatner
Apoptosis predominates in nonmyocytes in heart failure
Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H785 - H791.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
J. Xiao, Q. She, Y. Wang, K. Luo, Y. Yin, R. Hu, and K. Huang
Effect of allopurinol on cardiomyocyte apoptosis in rats after myocardial infarction
Eur J Heart Fail, January 1, 2009; 11(1): 20 - 27.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. Chao
Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart
Am J Physiol Heart Circ Physiol, January 1, 2009; 296(1): H1 - H12.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. N. Salloum, A. Abbate, A. Das, J.-E. Houser, C. A. Mudrick, I. Z. Qureshi, N. N. Hoke, S. K. Roy, W. R. Brown, S. Prabhakar, et al.
Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1398 - H1406.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
V. Subramanian, P. Krishnamurthy, K. Singh, and M. Singh
Lack of osteopontin improves cardiac function in streptozotocin-induced diabetic mice
Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H673 - H683.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
M. Xiang, J. Wang, E. Kaplan, P. Oettgen, L. Lipsitz, J. P. Morgan, and J.-Y. Min
Antiapoptotic Effect of Implanted Embryonic Stem Cell-Derived Early-Differentiated Cells in Aging Rats After Myocardial Infarction
J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2006; 61(12): 1219 - 1227.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
X. Liu, X. Gu, Z. Li, X. Li, H. Li, J. Chang, P. Chen, J. Jin, B. Xi, D. Chen, et al.
Neuregulin-1/erbB-Activation Improves Cardiac Function and Survival in Models of Ischemic, Dilated, and Viral Cardiomyopathy
J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1438 - 1447.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Lehrke, R. Mazhari, D. J. Durand, M. Zheng, D. Bedja, J. M. Zimmet, K. H. Schuleri, A. S. Chi, K. L. Gabrielson, and J. M. Hare
Aging Impairs the Beneficial Effect of Granulocyte Colony-Stimulating Factor and Stem Cell Factor on Post-Myocardial Infarction Remodeling
Circ. Res., September 1, 2006; 99(5): 553 - 560.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Matsusaka, T. Ide, S. Matsushima, M. Ikeuchi, T. Kubota, K. Sunagawa, S. Kinugawa, and H. Tsutsui
Targeted deletion of p53 prevents cardiac rupture after myocardial infarction in mice
Cardiovasc Res, June 1, 2006; 70(3): 457 - 465.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Matsushima, T. Ide, M. Yamato, H. Matsusaka, F. Hattori, M. Ikeuchi, T. Kubota, K. Sunagawa, Y. Hasegawa, T. Kurihara, et al.
Overexpression of Mitochondrial Peroxiredoxin-3 Prevents Left Ventricular Remodeling and Failure After Myocardial Infarction in Mice
Circulation, April 11, 2006; 113(14): 1779 - 1786.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
P. van der Meer, E. Lipsic, R. H. Henning, R. A. de Boer, A. J.H. Suurmeijer, D. J. van Veldhuisen, and W. H. van Gilst
Erythropoietin improves left ventricular function and coronary flow in an experimental model of ischemia-reperfusion injury
Eur J Heart Fail, December 1, 2004; 6(7): 853 - 859.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
K. Doi, K. Hasegawa, M. Fujita, A. Yamazato, K. Yamanaka, M. Watanabe, K. Tambara, and M. Komeda
Clinical characteristics relevant to myocardial cell apoptosis: analysis of pericardial fluid
Interactive CardioVascular and Thoracic Surgery, June 1, 2004; 3(2): 359 - 362.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Ahn, L. Cheng, C. Moon, H. Spurgeon, E. G. Lakatta, and M. I. Talan
Induction of myocardial infarcts of a predictable size and location by branch pattern probability-assisted coronary ligation in C57BL/6 mice
Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H1201 - H1207.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
O. Tarnavski, J. R. McMullen, M. Schinke, Q. Nie, S. Kong, and S. Izumo
Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies
Physiol Genomics, February 13, 2004; 16(3): 349 - 360.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. K.W. Au-Yeung, C. W.H. Woo, F. L. Sung, J. C.W. Yip, Y. L. Siow, and K. O
Hyperhomocysteinemia Activates Nuclear Factor-{kappa}B in Endothelial Cells via Oxidative Stress
Circ. Res., January 9, 2004; 94(1): 28 - 36.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
W. M. Yarbrough, R. Mukherjee, G. P. Escobar, J. A. Sample, J. E. McLean, K. B. Dowdy, J. W. Hendrick, W. C. Gibson, A. E. Hardin, J. T. Mingoia, et al.
Pharmacologic inhibition of intracellular caspases after myocardial infarction attenuates left ventricular remodeling: a potentially novel pathway
J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 1892 - 1899.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Hayashidani, H. Tsutsui, M. Ikeuchi, T. Shiomi, H. Matsusaka, T. Kubota, K. Imanaka-Yoshida, T. Itoh, and A. Takeshita
Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction
Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1229 - H1235.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Shiomi, H. Tsutsui, M. Ikeuchi, H. Matsusaka, S. Hayashidani, N. Suematsu, J. Wen, T. Kubota, and A. Takeshita
Streptozotocin-induced hyperglycemia exacerbates left ventricular remodeling and failure after experimental myocardial infarction
J. Am. Coll. Cardiol., July 2, 2003; 42(1): 165 - 172.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. A. Fortuno, A. Gonzalez, S. Ravassa, B. Lopez, and J. Diez
Clinical implications of apoptosis in hypertensive heart disease
Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1495 - H1506.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. Mani and R. N. Kitsis
Myocyte apoptosis: programming ventricular remodeling
J. Am. Coll. Cardiol., March 5, 2003; 41(5): 761 - 764.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. E. Regan, M. Broad, A. M. Byford, A. R. Lankford, R. J. Cerniway, M. W. Mayo, and G. P. Matherne
A1 adenosine receptor overexpression attenuates ischemia-reperfusion-induced apoptosis and caspase 3 activity
Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H859 - H866.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Nomoto, T. Nishina, S. Miwa, H. Tsuneyoshi, I. Maruyama, K. Nishimura, and M. Komeda
Angiotensin-Converting Enzyme Inhibitor Helps Prevent Late Remodeling After Left Ventricular Aneurysm Repair in Rats
Circulation, September 24, 2002; 106(12_suppl_1): I-115 - I-119.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
N. A. Trueblood, Z. Xie, C. Communal, F. Sam, S. Ngoy, L. Liaw, A. W. Jenkins, J. Wang, D. B. Sawyer, O. H. L. Bing, et al.
Exaggerated Left Ventricular Dilation and Reduced Collagen Deposition After Myocardial Infarction in Mice Lacking Osteopontin
Circ. Res., May 25, 2001; 88(10): 1080 - 1087.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
F. Sam, D. B. Sawyer, Z. Xie, D. L.F. Chang, S. Ngoy, D. A. Brenner, D. A. Siwik, K. Singh, C. S. Apstein, and W. S. Colucci
Mice Lacking Inducible Nitric Oxide Synthase Have Improved Left Ventricular Contractile Function and Reduced Apoptotic Cell Death Late After Myocardial Infarction
Circ. Res., August 17, 2001; 89(4): 351 - 356.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (88)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sam, F.
Right arrow Articles by Colucci, W. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sam, F.
Right arrow Articles by Colucci, W. S.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online